MANNKIND CORP's ticker is MNKD and the CUSIP is 56400P706. A total of 152 filers reported holding MANNKIND CORP in Q4 2020. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $282,800 | +10.8% | 68,475 | +9.6% | 0.00% | – |
| Q2 2023 | $255,220 | -10.5% | 62,467 | -11.1% | 0.00% | -100.0% |
| Q1 2023 | $285,197 | -27.2% | 70,232 | -5.5% | 0.00% | 0.0% |
| Q4 2022 | $391,620 | +79.6% | 74,332 | +5.4% | 0.00% | – |
| Q3 2022 | $218,000 | -17.1% | 70,501 | +3.8% | 0.00% | -100.0% |
| Q2 2022 | $263,000 | -74.9% | 67,901 | +1.2% | 0.00% | -50.0% |
| Q1 2022 | $1,047,000 | +262.3% | 67,091 | +1.8% | 0.00% | +100.0% |
| Q4 2021 | $289,000 | -23.5% | 65,891 | -23.6% | 0.00% | 0.0% |
| Q3 2021 | $378,000 | -19.1% | 86,206 | +0.5% | 0.00% | 0.0% |
| Q2 2021 | $467,000 | +7.6% | 85,766 | -20.9% | 0.00% | 0.0% |
| Q1 2021 | $434,000 | +37.3% | 108,387 | +7.5% | 0.00% | 0.0% |
| Q4 2020 | $316,000 | +61.2% | 100,797 | -6.9% | 0.00% | 0.0% |
| Q3 2020 | $196,000 | +9.5% | 108,285 | +5.9% | 0.00% | 0.0% |
| Q2 2020 | $179,000 | +90.4% | 102,246 | +6.6% | 0.00% | – |
| Q1 2020 | $94,000 | – | 95,886 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 1492 Capital Management LLC | 557,051 | $2,050,000 | 1.09% |
| 180 WEALTH ADVISORS, LLC | 1,369,904 | $4,877,000 | 1.06% |
| EMERALD ADVISERS, LLC | 5,675,539 | $20,886,000 | 0.80% |
| DG Capital Management, LLC | 1,035,693 | $3,811,000 | 0.76% |
| Parkman Healthcare Partners LLC | 675,403 | $2,485,000 | 0.73% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 4,358,087 | $16,038,000 | 0.71% |
| Avoro Capital Advisors LLC | 8,800,000 | $32,384,000 | 0.59% |
| Monarch Partners Asset Management LLC | 420,478 | $1,547,000 | 0.35% |
| Bruce & Co., Inc. | 395,073 | $1,453,000 | 0.30% |
| SCOPIA CAPITAL MANAGEMENT LP | 694,961 | $2,557,000 | 0.23% |